PHARMACOSMOS A/S: Financial statements 2024
CVR: 15517085
Source: annual report 2024, Danish Business Authority
01/05/2023 – 30/04/2024
PHARMACOSMOS A/S (CVR 15517085) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,613,141,000 and a net result of DKK 789,701,000 compared with DKK 114,274,000 the year before. That is an increase of 46.1% compared with the year before. The profit margin was 49%. Equity in the 2024 report amounted to DKK 1,635,784,000. The solvency ratio was 61.5%. The company had 208 employees in the financial year.
- Revenue
- DKK 1,613,141,000
- Gross Profit
- DKK 1,245,363,000
- Profit/Loss
- DKK 789,701,000
- Equity
- DKK 1,635,784,000
- Total Assets
- DKK 2,657,695,000
- Employees
- 208
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.6B | 1.2B | 789.7M | 1.6B | 208 |
| 2023 | 1.1B | 674.1M | 114.3M | 854.6M | 191 |
| 2022 | 876.8M | 545.5M | 170M | 807.5M | 468 |
| 2021 | 782.2M | 464.9M | -136M | 642.8M | 352 |
| 2020 | 609.1M | 328.9M | 56.5M | 884M | 258 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of June 27, 2024, Milena Jordanova Olsen has joined the board of directors of PHARMACOSMOS A/S.
As of June 27, 2024, Lars Green has joined the board of directors of PHARMACOSMOS A/S.
As of June 27, 2024, Tommy Pedersen has left the board of directors of PHARMACOSMOS A/S.
About PHARMACOSMOS A/S
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named PHARMACOSMOS PHARMACEUTICALS A/S and SOLOCHEM A/S. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 327 employees (2026). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.